Percy H. Carter insider trades
Open-market stock purchases and sales by Percy H. Carter, Chief Scientific Officer at Blueprint Medicines Corp, from SEC Form 4 filings since Jun 1, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BPMC Blueprint Medicines Corp: 11 sales, last Jul 17, 2025